Indeed. I wonder though, with the P2 and P3 trials in Canada - can this data and the findings also be used to support TGA approval in Australia? Or would CPH need to conduct its own local trials to support use of psilocybin as a therapy here?
Indeed. I wonder though, with the P2 and P3 trials in Canada -...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)